Comparer des méthodes
Examinez les méthodes sélectionnées côte à côte ; les lignes qui diffèrent sont mises en évidence.
| FACT-Lung : Évaluation fonctionnelle des thérapies anticancéreuses× | EORTC QLQ-LC13 : Qualité de vie dans le cancer du poumon× | |
|---|---|---|
| Domaine | Oncologie | Oncologie |
| Famille | Process / pipeline | Process / pipeline |
| Année d'origine≠ | 1995 | 1994 |
| Auteur d'origine≠ | David F. Cella, Ph.D. | Bergman, B., et al. (EORTC Quality of Life Group) |
| Type | Self-report questionnaire | Self-report questionnaire |
| Source fondatrice≠ | Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument for patients with lung cancer. J Clin Oncol, 13(1), 142–153. link ↗ | Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗ |
| Alias | FACT-L | QLQ-LC13 |
| Apparentées | 5 | 5 |
| Résumé≠ | The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is widely used in clinical trials and practice to assess treatment impact and symptom burden. | The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials. |
| ScholarGateJeu de données ↗ |
|
|